SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

HUTCHMED Says FDA Granted Sovleplenib Orphan Drug Designation

The designation is for sovleplenib in autoimmune hemolytic anemia.

Related stories